Journal article
Neurodevelopment of Children Following Prenatal Exposure to Venlafaxine, Selective Serotonin Reuptake Inhibitors, or Untreated Maternal Depression
Abstract
OBJECTIVE: Effects on child neurodevelopment of neurotransmitter reuptake inhibitors used as antidepressants during pregnancy have not been adequately studied. The authors compared the effects of prenatal exposure to venlafaxine (serotonin-norepinephrine reuptake inhibitor), selective serotonin reuptake inhibitors (SSRIs), and maternal depression.
METHOD: A cohort derived from a prospectively collected database included four groups of children …
Authors
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Journal
American Journal of Psychiatry, Vol. 169, No. 11, pp. 1165–1174
Publisher
American Psychiatric Association Publishing
Publication Date
November 2012
DOI
10.1176/appi.ajp.2012.11111721
ISSN
0002-953X
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Abnormalities, Drug-InducedAdultAntidepressive Agents, Second-GenerationCase-Control StudiesChild Behavior DisordersChild, PreschoolCyclohexanolsDepressive DisorderDose-Response Relationship, DrugFemaleHumansInfantInfant, NewbornIntelligenceLongitudinal StudiesMaleNeonatal Abstinence SyndromePregnancyPregnancy ComplicationsPrenatal Exposure Delayed EffectsProspective StudiesReference ValuesRetrospective StudiesSelective Serotonin Reuptake InhibitorsSex FactorsVenlafaxine HydrochlorideWechsler Scales